Are you Dr. Tian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 25 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6435 River Crest Dr
Clemmons, NC 27012Phone+1 501-804-3545- Is this information wrong?
Summary
- Dr. Shaozhou Tian, MD is a board certified pathologist in Clemmons, North Carolina. He is currently licensed to practice medicine in North Carolina and New York.
Education & Training
Wake Forest University School of MedicineResidency, Pathology-Anatomic and Clinical, 2010 - 2014
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2010
Certifications & Licensure
NY State Medical License 2014 - 2025
NC State Medical License 2010 - 2014- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 59 citationsOptimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience.Shaozhou Ken Tian, J. Keith Killian, Natasha Rekhtman, Ryma Benayed, Sumit Middha, Marc Ladanyi, Oscar Lin, Maria E. Arcila> ;Archives of Pathology & Laboratory Medicine. 2016 Sep 2
- 272 citationsNext-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like SubsetsNatasha Rekhtman, Maria Catherine Pietanza, Matthew D. Hellmann, Jarushka Naidoo, Arshi Arora, Helen Won, Darragh Halpenny, Hangjun Wang, Shaozhou K. Tian, Anya Litvak...> ;Clinical Cancer Research. 2016 Jul 15
- 184 citationsAcquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase DomainHelena A. Yu, Shaozhou K. Tian, Alexander Drilon, Laetitia Borsu, Gregory J. Riely, Maria E. Arcila, Marc Ladanyi> ;JAMA Oncology. 2015 Oct 1
